Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, which may be a promising option for patients with cancer. Overview The Scientific Director, Medical Affairs, and will represent Iovance Medical Affairs as needed, serving as a TIL cell therapy therapeutic area expert in educational, strategic, and tactical discussions/presentations with internal colleagues as well as external experts and investigators. Strong surgical and/or cell therapy expertise and recent clinical experience is required as this individual will be responsible for engagement and education with external HCP stakeholders. This role requires the ability to partner effectively with surgeons and apply practical insights into tumor procurement and perioperative workflows. They will support advisory board meetings and congress scientific forum planning. They will also collaborate with cross-functional teams to ensure the alignment of medical strategies with overarching corporate objectives. Essential Functions and Responsibilities   Responsibilities will include, but are not limited to, the following: ⢠Represent Iovance Medical Affairs as a TIL cell therapy expert in both internal and external venues including the US and Global cross-functional teams, MRB, external consults, clinical sub-teams, and advisory boards / steering committees. ⢠Work cross-functionally to support Commercial Quality, Market Access, Clinical Development, and the broader Med Affairs team. Please mention the word **ALTRUISTIC** and tag RMTYyLjIyMC4yMzIuMTY4 when applying to show you read the job post completely (#RMTYyLjIyMC4yMzIuMTY4). This is a beta feature to avoid spam applicants. Companies can search these words to find applicants that read this and see they're human.